T-CELL IMMUNITY TO ONCOGENIC PROTEINS INCLUDING MUTATED RAS AND CHIMERIC BCR-ABL

被引:0
|
作者
CHEEVER, MA [1 ]
CHEN, W [1 ]
DISIS, ML [1 ]
TAKAHASHI, M [1 ]
PEACE, DJ [1 ]
机构
[1] LOYOLA UNIV, DEPT MED, MAYWOOD, IL 60153 USA
关键词
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:101 / 112
页数:12
相关论文
共 50 条
  • [41] Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins
    Degauque, Nicolas
    Mariat, Christophe
    Kenny, James
    Sanchez-Fueyo, Alberto
    Alexopoulos, Sophoclis P.
    Kuchroo, Vijay
    Zheng, Xin-Xiao
    Strom, Terry B.
    TRANSPLANTATION, 2007, 84 (01) : S12 - S16
  • [42] Comparative Effects of Wild Type and T315I Mutated bcr-ABL in Murine Embryonic Stem-Cell Derived Hematopoiesis.
    Melkus, Michael
    Mitjavila-Garcia, Maria Theresa
    Bonnet, Marie-Laure
    Sorel, Nathalie
    Chomel, Jean-Claude
    Bennaceur-Griscelli, Annelise
    Turhan, Ali G.
    BLOOD, 2008, 112 (11) : 393 - 393
  • [43] T-Cell acute lymphoblastic leukemia with a pinch of BCR-ABL1
    Cortes, Jorge
    De Keersmaecker, Kim
    LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 321 - 322
  • [44] Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I
    Gontarewicz, Artur
    Balabanov, Stefan
    Keller, Gunhild
    Colombo, Riccardo
    Graziano, Alessio
    Pesenti, Enrico
    Benten, Daniel
    Bokemeyer, Carsten
    Fiedler, Walter
    Moll, Juergen
    Bruemmendorf, Tim H.
    BLOOD, 2008, 111 (08) : 4355 - 4364
  • [45] Electronic and structural study of T315I mutated form in DFG-out conformation of BCR-ABL inhibitors
    Pereira, Washington A.
    Nascimento, Erica C. M.
    Martins, Joao B. L.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (20): : 9774 - 9788
  • [46] Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy
    Sandt, Christophe
    Feraud, Olivier
    Bonnet, Marie-Laure
    Desterke, Christophe
    Khedhir, Rania
    Flamant, Stephane
    Bailey, Charles G.
    Rasko, John E. J.
    Dumas, Paul
    Bennaceur-Griscelli, Annelise
    Turhan, Ali G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1861 - 1867
  • [47] Oncogenic transformation of NIH 3T3 fibroblasts by BCR-ABL oncoprotein requires the IL-3 receptor
    Tao, Wenjing
    Lin, Hui
    Sun, Tong
    Samanta, Ajoy K.
    Arlinghaus, Ralph B.
    BLOOD, 2007, 110 (11) : 988A - 988A
  • [48] Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses
    Pinilla-Ibarz, Javier
    Korontsvit, Tatyana
    Zakhaleva, Victoriya
    Roberts, Wendy
    Scheinberg, David A.
    HAEMATOLOGICA, 2005, 90 (10) : 1324 - 1332
  • [49] HUMAN LYMPHOCYTES-T RECOGNIZE A PEPTIDE OF SINGLE POINT-MUTATED, ONCOGENIC RAS PROTEINS
    JUNG, S
    SCHLUESENER, HJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01): : 273 - 276
  • [50] Oncogenic stress induced by Bcr-Abl over-activation leads to cell death mediated by a massively enhanced aerobic glycolysis
    Dengler, Michael A.
    Staiger, Annette
    Gutekunst, Matthias
    Hofmann, Ute
    Aulitzky, Walter E.
    van der Kuip, Heiko
    CANCER RESEARCH, 2011, 71